Cannabinoids in Gynecological Diseases

Area of Science:

• Reproductive biology
• Endocrinology
• Pharmacology

Background:

• The endocannabinoid system (ECS) is a crucial homeostatic regulator involved in numerous physiological and pathological processes.
• Endocannabinoids and exogenous cannabinoids (phyto- and synthetic) interact with various receptors, including CB1, CB2, GPR18, GPR55, TRP channels, and PPARs.
• The ECS plays a significant role in all aspects of female reproduction, from oocyte development to childbirth.

Purpose of the Study:

• To explore the role of the endocannabinoid system (ECS) in female reproduction.
• To investigate the association between ECS dysregulation and gynecological disorders.
• To evaluate the therapeutic potential of cannabinoids for gynecological conditions.

Main Methods:

• Review of scientific literature on the endocannabinoid system and female reproduction.
• Analysis of the mechanisms of action of cannabinoids on ECS receptors.
• Examination of the link between ECS dysregulation and gynecological pathologies.

Main Results:

• The ECS is integral to female reproductive functions, including ovulation, implantation, and parturition.
• Dysregulation of the ECS is implicated in gynecological disorders such as infertility, endometriosis, and gynecological cancers.
• Cannabinoids acting as agonists or antagonists on the ECS show promise in addressing these dysregulations.

Conclusions:

• The endocannabinoid system is a key regulator of female reproductive health.
• Targeting the ECS with specific cannabinoid agonists or antagonists presents a promising avenue for novel therapeutic strategies in gynecology.
• Further research into cannabinoid-based therapies could revolutionize the treatment of various gynecological disorders.